Skip to main content
  • EHA

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
    • About EHA
    • CME
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact

More articles from Myeloproliferative Disorders

  • Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
    Barbara Mora, Toni Giorgino, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami Komrokji, Jason Gotlib, Jean-Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T. Silver, Giulia Benevolo, Francesco Albano, Chiara Cavalloni, Daniela Barraco, Michele Merli, Daniela Pietra, Rosario Casalone, Tiziano Barbui, Giada Rotunno, Mario Cazzola, Alessandro Maria Vannucchi, Francesco Passamonti
    Haematologica Apr 2018, haematol.2017.185751; DOI: 10.3324/haematol.2017.185751
  • Impact of hydroxycarbamide and interferon-α on red cell adhesion and membrane protein expression in polycythemia vera
    Mégane Brusson, Maria De Grandis, Sylvie Cochet, Sylvain Bigot, Mickaël Marin, Marjorie Leduc, François Guillonneau, Patrick Mayeux, Thierry Peyrard, Christine Chomienne, Caroline Le Van Kim, Bruno Cassinat, Jean-Jacques Kiladjian, Wassim El Nemer
    Haematologica Mar 2018, haematol.2017.182303; DOI: 10.3324/haematol.2017.182303
  • Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)
    Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, Adrian Tempescul, Florence Dalbies, Jean-Richard Eveillard, Valérie Ugo, Stéphane Giraudier, Gaëlle Guillerm, Eric Lippert, Christian Berthou, Jean-Christophe Ianotto
    Haematologica Apr 2018, 103 (4) 607-613; DOI: 10.3324/haematol.2017.180448
  • Germline JAK2 L611S mutation in a child with thrombocytosis
    Bernard Aral, Martine Courtois, Sylviane Ragot, Valentin Bourgeois, Elodie Bottollier-Lemallaz, Claire Briandet, François Girodon
    Haematologica Mar 2018, haematol.2018.188995; DOI: 10.3324/haematol.2018.188995
  • GATA1s exerts developmental stage-specific effects in human hematopoiesis
    Sofia Gialesaki, Anna Katharina Mahnken, Lena Schmid, Maurice Labuhn, Raj Bhayadia, Dirk Heckl, Jan-Henning Klusmann
    Haematologica Mar 2018, haematol.2018.191338; DOI: 10.3324/haematol.2018.191338
  • Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
    Constance Baer, Verena Muehlbacher, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach
    Haematologica Mar 2018, haematol.2017.187302; DOI: 10.3324/haematol.2017.187302
  • JAK2V617F-bearing vascular niche enhances malignant hematopoietic regeneration following radiation injury
    Chi Hua Sarah Lin, Yu Zhang, Kenneth Kaushansky, Huichun Zhan
    Haematologica Mar 2018, haematol.2017.185736; DOI: 10.3324/haematol.2017.185736
  • The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
    Mathias Schneeweiss, Barbara Peter, Siham Bibi, Gregor Eisenwort, Dubravka Smiljkovic, Katharina Blatt, Mohamad Jawhar, Daniela Berger, Gabriele Stefanzl, Susanne Herndlhofer, Georg Greiner, Gregor Hoermann, Emir Hadzijusufovic, Karoline V. Gleixner, Peter Bettelheim, Klaus Geissler, Wolfgang R. Sperr, Andreas Reiter, Michel Arock, Peter Valent
    Haematologica Feb 2018, haematol.2017.179895; DOI: 10.3324/haematol.2017.179895
  • Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study
    Gunnar Birgegård, Carlos Besses, Martin Griesshammer, Luigi Gugliotta, Claire N. Harrison, Mohamed Hamdani, Jingyang Wu, Heinrich Achenbach, Jean-Jacques Kiladjian
    Haematologica Jan 2018, 103 (1) 51-60; DOI: 10.3324/haematol.2017.174672
  • Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models
    Jieyu Wang, Yoshihiro Hayashi, Asumi Yokota, Zefeng Xu, Yue Zhang, Rui Huang, Xiaomei Yan, Hongyun Liu, Liping Ma, Mohammad Azam, James P. Bridges, Jose A. Cancelas, Theodosia A. Kalfa, Xiuli An, Zhijian Xiao, Gang Huang
    Haematologica Jan 2018, 103 (1) 40-50; DOI: 10.3324/haematol.2017.172775

Pages

  • Next
  • 1
  • 2
  • 3
  • 4

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies
    • About EHA
    • CME

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles
  • EHA Education Book
  • EHA Education Tools
  • CME

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

EHA

  • About EHA
  • Become a member of EHA
  • EHA events
  • EHA education tools
  • EHA Corporate Sponsors

Copyright © 2018 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online